Evidence map›Paper›PMID 34748388›Full record

ArticleJournal of bacteriology2022

A Practical Guide to Small Protein Discovery and Characterization Using Mass Spectrometry.

Christian H Ahrens, Joseph T Wade, Matthew M Champion, Julian D Langer

Abstract read
In one paragraph

Article in Journal of bacteriology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The Proteome ofProteomes · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. CXXC5 is a ubiquitinated protein and is degraded by the ubiquitin-proteasome pathway.Protein science : a publication of the Protein Society · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christian H AhrensAgroscopegrid.417771.3, Method Development and Analytics & SIB Swiss Institute of Bioinformatics, Wädenswil, Switzerland.ORCID 0000-0002-8148-7257
Joseph T WadeWadsworth Center, New York State Department of Health, Albany, New York, USA.ORCID 0000-0002-9779-3160
Matthew M ChampionDepartment of Chemistry and Biochemistry, University of Notre Damegrid.131063.6, Notre Dame, Indiana, USA.ORCID 0000-0001-5927-5277
Julian D LangerMass Spectrometry and Proteomics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.ORCID 0000-0002-5190-577X

Funding

Systematic Discovery and Analysis of Small Proteins and Small ORFs in MycobacteriaR01GM139277 · NIGMS · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, GRAY, TODD · 2020 to 2023
$2.2M
NIGMS NIH HHS R01 GM139277NIGMS NIH HHS R01GM139277Swiss National Science Foundation 197391
6 · The paper itself

Abstract

Small proteins of up to ∼50 amino acids are an abundant class of biomolecules across all domains of life. Yet due to the challenges inherent in their size, they are often missed in genome annotations, and are difficult to identify and characterize using standard experimental approaches. Consequently, we still know few small proteins even in well-studied prokaryotic model organisms. Mass spectrometry (MS) has great potential for the discovery, validation, and functional characterization of small proteins. However, standard MS approaches are poorly suited to the identification of both known and novel small proteins due to limitations at each step of a typical proteomics workflow, i.e., sample preparation, protease digestion, liquid chromatography, MS data acquisition, and data analysis. Here, we outline the major MS-based workflows and bioinformatic pipelines used for small protein discovery and validation. Special emphasis is placed on highlighting the adjustments required to improve detection and data quality for small proteins. We discuss both the unbiased detection of small proteins and the targeted analysis of small proteins of interest. Finally, we provide guidelines to prioritize novel small proteins, and an outlook on methods with particular potential to further improve comprehensive discovery and characterization of small proteins.

Indexed as

ArchaeaArchaeal ProteinsBacteriaBacterial ProteinsComputational BiologyGene Expression Regulation, ArchaealGene Expression Regulation, BacterialMass SpectrometryArchaeal ProteinsBacterial Proteinsgenome annotationLC-MS/MSmicroproteinproteomicssample preparationSEPshotgun proteomicssmall proteinsproteinstop-down proteomics

Identifiers

PMID34748388
PMCPMC8765459

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.